COMMUNIQUÉS West-GlobeNewswire

Ziopharm Oncology Announces FDA Fast Track Designation for Ad-RTS-hIL-12 plus Veledimex for the Treatment of Recurrent Glioblastoma
01/04/2019
BOSTON, April 01, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP), a clinical stage immuno-oncology company developing next generation cell and gene therapies, today announced that the U.S. Food and [...]
Retail Cannabis Officially Hits Ontario Today Through Hobo Recreational Cannabis Store
01/04/2019
One of only three retail locations slated for Ottawa, Hobo’s launch comes on the heels of the province’s new cannabis retail model OTTAWA, April 01, 2019 (GLOBE NEWSWIRE) -- Hobo Recreational Cannabis Store (“ Hobo ”), [...]
Merus et Incyte présentent les données précliniques du programme MCLA-145 lors du congrès annuel 2019 de l'AACR
01/04/2019
Anticorps bispécifique CD137 et PD-L1 avec activation des lymphocytes T dépendante du contexte UTRECHT, Pays-Bas, 01 avr. 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS) (« Merus », « nous », « notre », « nos » ou [...]
Exactus Appoints Troy Rhonemus to Advisory Board
01/04/2019
Troy Rhonemus will Join Emiliano Aloi, President and Advisory Board Member, to Guide the Company on the Path to Setting Industry Standards on Regulatory Strategy and Farming Techniques DELRAY BEACH, Fla., April 01, 2019 [...]
HEXO completes first harvest in its 1 million sq. ft. greenhouse
01/04/2019
GATINEAU, Quebec, April 01, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (TSX: HEXO ; NYSE-A: HEXO ) (“HEXO” or the "Company") has completed the first harvest in its 1 million sq. ft. expansion, marking an important execution [...]
HEXO effectue sa première récolte dans sa serre d’un million de pieds carrés
01/04/2019
GATINEAU, Québec, 01 avr. 2019 (GLOBE NEWSWIRE) -- HEXO Corp (TSX: HEXO ; NYSE-A: HEXO ) (« HEXO » ou la « Société ») a effectué la première récolte dans sa serre agrandie d’un million de pieds carrés, marquant ainsi [...]
New CEO Leads Terumo BCT’s Ambition to Shape the Future of Blood and Cell Technologies in Healthcare
01/04/2019
Antoinette Gawin Focuses on Terumo BCT’s Potential to Treat Disease and Play a Greater Role in Cell Therapy and Regenerative Medicine—Serving More Patients LAKEWOOD, Colo., April 01, 2019 (GLOBE NEWSWIRE) -- Antoinette [...]
MannKind Receives $12.5 Million Milestone Payment from United Therapeutics
01/04/2019
WESTLAKE VILLAGE, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that it achieved the first of several specified development milestones under its licensing and [...]
Announcement About Convening of the Extraordinary General Meeting of Shareholders of Joint Stock Company “Olainfarm”
01/04/2019
Management Board of the Joint Stock Company Olainfarm (JSC Olainfarm), unitary registration number. 40003007246, registered address: Rupnicu iela 5, Olaine, LV-2114, announces that on April 1st, 2019, request to convene [...]
TLC Reports Fourth Quarter and Full Year 2018 Financial Results and Business Update
01/04/2019
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, April 01, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of [...]
Wildflower est mentionné dans une publication de NetworkNewsWire consacrée aux possibilités associées à la popularité grandissante du CBD
01/04/2019
NEW YORK, 01 avr. 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) a annoncé aujourd’hui être mentionnée dans un éditorial publié par NetworkNewsWire (« NNW »), une entreprise [...]
Enzymatica AB: - Publication of the annual report 2018
01/04/2019
Press release 1 April, 2019 Enzymatica - publication of the annual report 2018 Enzymatica announces today that the annual report 2018 is available on the company's web site www.enzymatica.se . The annual report is [...]
Press release: Terveystalo continues to grow its footprint in well-being services: Kajaanin OMT-Fysioterapia Oy to become part of Terveystalo
01/04/2019
Terveystalo is acquiring Kajaanin OMT-Fysioterapia Oy as at 29 March 2019. The company’s employees will be transferred to Terveystalo as old employees and the operations will continue on the same premises as before in [...]
Neovacs announces an agreement with Biosyn GmbH to diversify its supply of Keyhole Limpet Hemocyanin (KLH)
01/04/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES AN AGREEMENT WITH BIOSYN GmbH TO DIVERSIFY ITS SUPPLY OF KEYHOLE LIMPET HEMOCYANIN (KLH ) Paris et Boston, april 1 st 2019 - 07h30 CEST - Neovacs (Euronext [...]
Néovacs annonce un accord avec Biosyn GmbH afin de diversifier son approvisionnement en Keyhole Limpet Hemocyanin (KLH)
01/04/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE N É OVACS ANNONCE UN ACCORD AVEC BIOSYN GmbH AFIN DE DIVERSIFIER SON APPROVISIONNEMENT EN KEYHOLE LIMPET HEMOCYANIN (KLH) Paris et Boston, le 1 er avril [...]
Novartis adds clinical and preclinical anti-inflammatory programs to portfolio with acquisition of IFM Tre
01/04/2019
Acquisition will give Novartis one clinical and two preclinical programs targeting the NLRP3 inflammasome, a key component of the innate immune system Selective inhibition of the NLRP3 inflammasome is a potentially [...]
ObsEva SA to Participate in Upcoming Investor Conferences
01/04/2019
Geneva, Switzerland and Boston, MA – April 1, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Innate Pharma highlights next generation of cancer immunotherapies at the American Association of Cancer Research (AACR) 2019 annual meeting
01/04/2019
INNATE PHARMA HIGHLIGHTS NEXT GENERATION OF CANCER IMMUNOTHERAPIES AT THE AMERICAN ASSOCIATION OF CANCER RESEARCH (AACR) 2019 ANNUAL MEETING New preclinical data highlights IPH5201 (anti-CD39) and IHP5301 (anti-CD73) [...]
Innate Pharma à l’AACR 2019 : nouvelles données sur la prochaine génération d’immunothérapies des cancers
01/04/2019
INNATE PHARMA A L’AACR 2019 : NOUVELLES DONNÉES SUR LA PROCHAINE GÉNÉRATION D’IMMUNOTHÉRAPIES DES CANCERS Nouvelles données précliniques sur IPH5201 (anti-CD39) et IPH5301 (anti-CD73) ciblant la voie adénosine Premières [...]

Pages